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Culture Expansion in Low-Glucose Conditions Preserves
Chondrocyte Differentiation and Enhances Their
Subsequent Capacity to Form Cartilage Tissue
in Three-Dimensional Culture
Hannah K. Heywood,1 Giovanna Nalesso,2 David A. Lee,1,* and Francesco Dell’Accio2,*
Abstract
Culture conditions that preserve a stable chondrocyte phenotype are desirable in cell-based cartilage repair to
maximize efficacy and clinical outcome. This study investigates whether low-glucose conditions will preserve
the chondrocyte phenotype during culture expansion. Articular chondrocytes were culture-expanded in media
supplemented with either low (1mM) or high (10mM) glucose. The metabolic phenotype, reactive oxygen spe-
cies generation, and mRNA expression of markers of differentiation or catabolism were assessed by reverse-tran-
scription quantitative polymerase chain reaction after four population doublings (PDs) and subsequent tissue
formation capacity determined using pellet cultures. Continuous monolayer culture was used to determine the
population doubling limit. After expansion in monolayer for four PDs, chondrocytes expanded in low-glucose
conditions exhibited higher expression of the differentiation markers SOX9 and COL2A1 and reduced expres-
sion of the catabolic metalloproteinase matrix metallopeptidase 13. When chondrocytes expanded in low glucose
were cultured in micropellets, they consistently generated more cartilaginous extracellular matrix than those ex-
panded in high glucose, as evaluated by wet weight, sulfated glycosaminoglycan content, and hydroxyproline
assay for collagen content. The same pattern was observed whether high or low glucose was used during the pel-
let culture. During expansion, chondrocytes in high-glucose generated 50% more reactive oxygen species than
low-glucose conditions, despite a lower dependence on oxidative phosphorylation for energy. Furthermore low-
glucose cells exhibited > 30% increased population doubling limit. These data suggests that low-glucose expan-
sion conditions better preserve the expression of differentiation markers by chondrocytes and enhance their
subsequent capacity to form cartilage in vitro. Therefore, low glucose levels should be considered for the expan-
sion of chondrocytes intended for tissue engineering applications.
Key words: chondrocyte; Crabtree effect; differentiation markers; glucose concentration; monolayer expansion
potential; regenerative potential; tissue engineering
Introduction
It is estimated that annually in the United Kingdom,*10,000 patients suffer cartilage damage warranting re-
pair.1 The ex vivo expansion of chondrocyte populations
via proliferation in monolayer is a fundamental part of cell
based cartilage repair strategies, including autologous chon-
drocyte implantation (ACI), a clinically established tech-
nique to repair chronic symptomatic isolated chondral
defects.2 To obtain sufficient cell numbers, chondrocytes re-
covered by biopsy are typically cultured for three to four
population doublings before re-implantation at high density
to the damaged area.2,3 The success of these procedures is
dependent on the capacity of the implanted cells to form car-
tilage once implanted in vivo.4,5
Chondrocytes lose their expression of differentiation
markers upon serial passaging, a phenomenon described
as ‘‘dedifferentiation.’’4,6,7 Importantly, dedifferentiation is
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associated with lost capacity of chondrocytes to regenerate
cartilage when implanted in vivo and with a worse clini-
cal outcome of ACI both in terms of structural repair and
symptoms.4,6–9 Specific gene expression profiles, including a
robust expression of the extracellular matrix (ECM) constit-
uent collagen type 2, can predict the subsequent regenerative
capacity of expanded chondrocytes.4,10,11 It is well estab-
lished that type II collagen and aggrecan are direct transcrip-
tional targets of SOX9.12,13 Thus optimal cell processing
techniques for ACI should aim to sustain the expression of
these genes within expanded cells, without unduly compro-
mising proliferation.
Typical monolayer expansion involves culture for several
weeks under atmospheric oxygen conditions in a high glu-
cose media (10–25mM glucose). By contrast, the native
environment is scarce in oxygen and glucose.14–17 The envi-
ronment experienced by chondrocytes is critical to their be-
havior, and it is well known that reduced oxygen conditions,
more comparable to the native niche, can support the chon-
drocyte phenotype and promotes redifferentiation of mono-
layer expanded chondrocytes.18–22
Estimates predict that glucose concentrations may reach as
low as 1mMwithin articular cartilage in vivo16 and chondro-
cytes appear well adapted to effectively obtain glucose from
this extracellular environment.16,23,24 Interestingly, oxygen
consumption of differentiated articular chondrocytes is de-
termined by glucose availability and is suppressed above a
threshold of about 5mM,25–28 indicating that these cells
are also metabolically sensitive to an altered glucose envi-
ronment. Therefore, this study investigates the effect of glu-
cose concentration on the preservation of chondrocyte
differentiation markers throughout expansion and their
potential to produce a cartilaginous ECM. Furthermore, we
test whether any difference induced by expansion in low-
glucose conditions is a stable feature or is transient.
Methods
Chondrocyte isolation and culture
Full-depth cartilage was dissected from bovine metacar-
palphalangeal joints of 18- to 24-month-old animals under
sterile conditions. Chondrocytes were isolated from the
ECM by sequential incubation at 37C in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 16mM
HEPES buffer, 1.6mM L-glutamine, 120mg/L ascorbic
acid, and 16% (v/v) fetal calf serum (FCS) (DMEM + 16%
FCS) with 5.7mg/mL pronase for 1 h followed by incuba-
tion in DMEM + 16% FCS with 100U/mL collagenase for
12 h. All reagents were from Sigma-Aldrich (Poole, United
Kingdom).
Freshly isolated chondrocytes isolated from at least four
animals were seeded into culture flasks at a density of
2 · 104 cells/cm2 and cultured under standard conditions of
20% (v/v) O2 and 5% CO2 with glucose-free DMEM+ 10%
(v/v) FBS, supplemented with 2mM L-glutamine, 18mM
HEPES buffer, 88U/mL penicillin, and 88mg/mL strepto-
mycin (all from Sigma-Aldrich). Cells obtained from the dif-
ferent animals were not pooled. The DMEM of half the
flasks from each donor was supplemented with 10mM glu-
cose (high-glucose medium) and the remaining half with
1mM glucose (low-glucose medium). Galactose (9mM) was
added to the low glucose media, ensuring osmotic balance.
Cell proliferation was monitored by manually counting the
cells in situ daily from representative fields of view from
each flask, captured with a microscope-mounted camera.
Once four population doublings were achieved, the cells
were detached with trypsin-EDTA (Sigma-Aldrich) and
resuspended in fresh culture media. A portion of the cell sus-
pension was used immediately for metabolic analysis, the de-
termination of reactive oxygen species (ROS) generation, or
tissue-forming potential (pellet culture). Gene expression fol-
lowing expansion for four population doublings was deter-
mined by quantitative polymerase chain reaction (qPCR),
described below. Additional monolayer cultures were main-
tained continuously in either low- or high-glucose media for
over 200 days to examine long-term proliferation characteris-
tics. For the long-term culture the flasks were passaged as they
reached 90% confluence using 1:8 split ratio.
Metabolic analysis
The cellular rates of glycolysis and oxidative phosphory-
lation were calculated from the rate of lactate release and
oligomycin-sensitive oxygen consumption, respectively. A
fluorescence-based oxygen biosensor with a 96-well plate for-
mat (BD Biosciences, Oxford, United Kingdom) was used to
monitor the dissolved oxygen concentration in cell suspen-
sions over time, using a method adapted from the suppliers
and described in detail previously.28 The oxygen consumption
rate of each sample was calculated from the gradient of the
oxygen–time curve and normalized to cell number. Additional
cell samples were treated with 2mg/mL oligomycin (Sigma-
Aldrich) to determine the F1F0 coupled oxygen consumption
rate, representative of oxidative phosphorylation.
The lactate released by the cells in suspension was deter-
mined from media samples collected at 30-min intervals, as
described in a previous study29 and summarized here. b nicotin-
amide adenine dinucleotide+ (bNAD) was reconstituted with
0.2mL of glycine buffer, 0.4mL of water, and 0.01mL of
lactate dehydrogenase suspension (1000U/mL, Sigma L3916)
per milligram of bNAD (Sigma-Aldrich). Two hundred eighty
microliters of the reconstituted bNAD+ reagent was added to
20lL of each sample and standards in duplicate with incuba-
tion at 37C for 30min. The concentration of lactate in the sam-
ples was calculated by comparison of the absorbance at 340nm
to lactate standards ranging in concentration from 0 to 5mM.
ROS generation
Cells were suspended at 1· 106 cells/mL in phosphate-
buffered saline containing 10 lM dihydroethidium (Invitro-
gen) and supplemented with either low or high glucose
according to the expansion conditions. Cellular fluorescence
(320-nm excitation, 590-nm emission) was monitored at
5-min intervals for 30min using a BMG fluostar optima fluo-
rimeter, during which the cells were incubated at 37C and
mixed by orbital shaking. The rate of fluorescence increase
was recorded as a measure of ROS generation and xan-
thine/xanthine oxidase (100 lM/10mU/mL) used as a posi-
tive control for superoxide generation.
Gene expression (RNA extraction, reverse
transcription, and qPCR)
Gene expression was performed on cells cultured in mono-
layer to four population doublings (PDs). Total RNA of
10 HEYWOOD ET AL.
monolayer cells was extracted using TRIzol reagent (Invitro-
gen) according to the manufacturer’s instructions, and RNA
yield was assessed using a NanoDrop spectrophotometer.
Five hundred nanograms of total RNA from each sample
was reverse transcribed to cDNA using Thermoscript
Reverse transcription kit (Invitrogen) with oligo dT primer
according to the manufacturer’s instructions. Quantitative
PCR was performed using a MX3000P thermal cycler (Stra-
tagene, La Jolla, CA) with 1 lL of cDNA (or water control)
in a 10-lL final reaction volume using hot-start DNA poly-
merase (Qiagen, Crawley, United Kingdom) in the presence
of SYBR green (Sigma-Aldrich), ROX dye (Invitrogen), and
0.25 lM of specific primers with melt curve analysis of the
final product. Details of the primers are available in Table
1. Gene expression was assessed using a standard curve pre-
pared by serial dilution of cDNA of freshly isolated chondro-
cytes with normalization to the geometric mean of b-actin
and b2 microglobulin (B2M) controls. Collagen, type X,
alpha 1 (COL10A1) and matrix metallopeptidase 13
(MMP13) are expected to have low expression in freshly iso-
lated cells, and therefore the standards were prepared by di-
lution series of a preliminary PCR amplification.
Pellet cultures
One million cells were centrifuged at 380 g in a 15-mL
tube to form a cell pellet and cultured in 4mL of either
low- or high-glucose media (described previously) with
loose caps under standard CO2 incubator conditions for 6
weeks, with medium replacement on alternate days. After
this time the wet weight of the cell pellets was recorded,
and the pellets were either frozen prior to biochemical anal-
ysis or fixed in 4% formaldehyde overnight for histological
analysis of ECM constituents. Samples for biochemical anal-
ysis were digested with papain as described previously,30
prior to the dimethylmethylene blue assay for quantification
of sulfated glycosaminoglycans31 and hydroxyproline assay,
for estimation of collagen content.32 Fixed samples were em-
bedded in paraffin wax and sectioned to 2lm for staining
with Alcian blue (pH 2.5) for sulfated glycosaminoglycans
or Sirius red for collagen content using standard protocols.
Statistical tests
Data was collected from at least four donor animals, which
were maintained separately during culture. Statistical com-
parisons were made by two-factor analysis of variance
(ANOVA) and subsequently two-tail t-tests, with Bonferroni
correction for multiple comparisons where appropriate.
Results
Expansion in low glucose resulted in a marginally longer
population doubling time
Chondrocytes lose their differentiated traits during culture
expansion in vitro.4,6,8 Therefore, the effect of glucose con-
centration on the rate and extent of chondrocyte expansion
in monolayer was determined. Population expansion pro-
gressed marginally, but consistently, more slowly in low-
glucose media compared with high-glucose cultures (Fig.
1A, B). Low-glucose cultures exhibited an extended lag
phase of 5.1 days compared with 4.3 days in high glucose
(Fig. 1C). The low-glucose cultures also exhibited an
T
a
b
l
e
1
.
P
r
im
e
r
S
e
q
u
e
n
c
e
s
U
se
d
fo
r
Q
u
a
n
t
it
a
t
iv
e
G
e
n
e
E
x
pr
e
ss
io
n
A
n
a
l
y
si
s
G
en
e
A
cc
es
si
o
n
n
o
.
S
en
se
A
n
ti
se
n
se
P
ro
d
u
ct
si
ze
(b
p
)
A
n
n
ea
li
n
g
te
m
p
(
C
)
b-
ac
ti
n
N
M
_
1
7
3
9
7
9
.3
A
G
C
A
G
T
C
G
G
T
T
G
G
A
T
C
G
A
G
C
A
G
G
G
A
A
G
G
C
A
A
A
G
G
A
C
T
T
C
C
T
G
T
A
A
C
1
3
7
6
0
B
2
M
N
M
_
1
7
3
8
9
3
.3
G
G
G
T
G
C
T
A
C
A
T
G
T
C
C
A
T
G
T
T
T
G
A
C
C
T
G
C
A
G
A
A
G
A
C
A
C
C
C
A
G
A
T
G
T
T
G
A
T
G
1
1
8
6
0
S
O
X
9
A
F
_
2
7
8
7
0
3
.1
A
C
T
C
T
G
G
G
C
A
A
G
C
T
C
T
G
G
A
G
A
C
T
G
G
C
G
C
G
G
C
T
G
G
T
A
C
T
T
G
T
A
G
T
C
C
1
2
1
6
0
C
O
L
2
A
1
N
M
_
0
0
1
0
0
1
1
3
5
.2
G
C
A
A
G
A
G
G
C
C
C
C
T
G
C
A
G
G
T
G
A
G
C
A
C
A
A
A
G
C
A
C
A
A
G
C
C
A
G
T
A
T
G
T
1
5
5
6
0
A
g
g
re
ca
n
N
M
_
1
7
3
9
8
1
.2
G
A
T
G
C
T
T
C
T
A
T
C
C
C
A
G
C
C
T
C
C
G
C
C
G
G
T
C
C
G
G
G
A
A
G
T
G
G
C
G
G
T
A
A
1
2
5
6
0
M
M
P
1
3
N
M
_
1
7
4
3
8
9
.2
A
G
C
A
C
C
C
T
T
C
C
C
A
T
G
A
C
C
T
T
A
T
C
T
T
C
C
T
C
A
A
A
G
T
G
A
A
G
G
G
C
T
G
C
G
C
1
5
4
6
0
C
O
L
1
0
A
1
N
M
_
1
7
4
6
3
4
.1
A
A
A
G
G
T
C
T
A
A
G
T
G
G
C
C
C
C
T
T
T
T
G
T
C
G
A
G
G
T
T
C
A
T
G
A
C
A
A
A
A
G
C
A
C
C
T
T
G
C
1
3
8
6
0
P
T
G
S
2
N
M
_
1
7
4
4
4
5
.2
A
C
T
C
A
C
C
A
G
C
C
C
A
C
A
G
A
G
A
A
C
G
T
T
C
C
C
T
T
T
G
C
C
T
A
A
C
A
G
G
C
A
T
A
C
C
T
2
2
5
5
5
B
2
M
,
b2
m
ic
ro
g
lo
b
u
li
n
;
C
O
L
2
A
1
,
co
ll
ag
en
,
ty
p
e
II
,
al
p
h
a
1
;
M
M
P
1
3
,
m
at
ri
x
m
et
al
lo
p
ep
ti
d
as
e
1
3
;
C
O
L
1
0
A
1
,
co
ll
ag
en
,
ty
p
e
X
,
al
p
h
a
1
;
P
T
G
S
2
,
p
ro
st
ag
la
n
d
in
-e
n
d
o
p
er
o
x
id
e
sy
n
th
as
e
2
.
GLUCOSE LEVELS & CHONDROCYTE FUNCTION 11
increased population doubling (PD) time of 2 days in compar-
ison with 1.6 days in high glucose, such that four PDs (consid-
ered a standard expansion for cell products used in ACI
procedures) were achieved by day 13 and day 11, respectively
(Fig. 1D). Interestingly, however, replicative potential was
consistently greater with long-term expansion in the low-glu-
cose condition, while chondrocytes cultured in high glucose
stopped dividing after approximately 30 PDs (Supplementary
Fig. S1), a potential indication of cumulative cell stress.33,34
Glucose conditions determine chondrocyte oxygen
metabolism and ROS throughout culture expansion
The metabolic phenotype of differentiated chondrocytes is
known to be responsive to glucose concentration, with oxida-
tive phosphorylation being suppressed by high-glucose con-
ditions (Crabtree effect).25–28 To confirm that low-glucose
conditions effectively modified the metabolism of chondro-
cytes in the present study, rates of glycolysis, aerobic metab-
olism, and ROS levels were investigated following four PDs,
which was considered a relevant time point because it is a
typical expansion required for ACI. Both oxidative phos-
phorylation and glycolysis (Fig. 2A, B) increased following
expansion compared to freshly isolated cells, in keeping with
previous reports.29 Chondrocytes exhibited significantly
greater oxidative phosphorylation in 1mM glucose com-
pared with 10mM glucose, both at day 0 and after four
PDs (Fig. 2). We calculate, using an ATP to O2 ratio of 5
(as reported by Brand et al.35) and an ATP to lactate ratio
of 1, that the cells expanded in low glucose derived 57%
of their ATP from aerobic metabolism, compared with
23% in high glucose (Fig. 2C). Increased ROS generation
was observed following monolayer culture expansion com-
pared to day 0 cells, and statistically significantly greater
ROS levels were observed following culture in high-glucose
than in low-glucose conditions (Fig. 2D), despite a lower de-
pendence on aerobic metabolism for ATP.
The stability of the acquired metabolic phenotype was
then investigated. If, after four PDs in low glucose, chondro-
cytes were switched to high glucose conditions and vice versa,
the metabolic differences observed between the expansion
conditions were mostly reversible (Fig. 3A–D). In particular,
chondrocytes expanded in 10mM glucose and resuspended
in 1mM glucose prior to analysis derived the same proportion
of ATP from aerobic metabolism (57%) as continuous culture
in 1mM glucose (Fig. 3C). Again, this switch towards oxida-
tive metabolism on transfer to 1mM glucose was accompa-
nied with decreasing ROS generation (Fig. 3D).
FIG. 1. Population expan-
sion kinetics and morphol-
ogy. Cell morphology at
different time points in either
1mM glucose or 10mM
glucose media (A). Pop-
ulation duplication dynamics:
Cells expanded in 1mM glu-
cose initially proliferated
more slowly (B), with an ex-
tended lag phase and in-
creased population doubling
time compared to 10mM
glucose cultures (C), such
that four population dou-
blings were obtained after 13
and 11 days, respectively (D).
Data represents the mean –
SD of four donors, and
p-values indicate significance
level of two-tailed paired
t-tests. PD, population
doubling.
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High-glucose conditions resulted in increased chondrocyte
dedifferentiation and irreversibly decreased capacity
to form cartilage tissue in three-dimensional culture in vitro
To investigate whether high- or low-glucose conditions
during culture expansion affected chondrocyte phenotype,
gene expression of key chondrocyte markers was compared
at the end of a 4-PD expansion period. As expected,4,6 the
mRNA expression of the differentiation markers SOX9, col-
lagen, type II, alpha 1 (COL2A1), and aggrecan all decreased
with culture expansion. However, after four PDs (the typical
expansion length for ACI), COL2A1 and SOX9 were more
expressed in chondrocytes that had been expanded in low-
glucose conditions (Fig. 4A). In addition, the expression of
MMP13, a proteolytic enzyme involved in ECM catabolism,
was significantly lower following expansion in low glucose
compared to the high-glucose expansion conditions (Fig.
4B). The expression of COL10A1 (a marker of chondrocyte
hypertrophic differentiation) and prostaglandin-endoperox-
ide synthase 2 (PTGS2), involved in the synthesis of prosta-
glandin E2) were not significantly affected by expansion
glucose level.
To investigate whether this difference in the chondrocyte
gene expression profile also resulted in increased cartilage
formation in vitro, chondrocytes expanded in either high-
or low-glucose condition for 4 PDs were replated in three-
dimensional (3D) pellets, a condition known to promote
the formation of cartilage organoids,8,36 all of them in high-
glucose medium. Consistent with the higher expression of
differentiation markers at the end of the expansion phase, car-
tilage tissue formation in pellet culture was more efficient when
the chondrocytes had been expanded in low glucose, exhibiting
48% greater wet weight and significantly greater GAG and col-
lagen per pellet (Figs. 5A–C, 6A) compared to cells expanded
in high glucose. Histochemical staining supported the presence
of cartilaginous ECMwithin the pellets, with Alcian blue stain-
ing for sulfated GAGs, and Sirius red for fibrillar collagens
(Fig. 6). Differences in the GAG and hydroxyproline content
of the pellets were not significant (two-way ANOVA) when
expressed as percent wet weight, indicating a greater amount
of qualitatively similar matrix in the two groups.
In ACI, in vitro expanded chondrocytes are implanted into
the joint defect where they face different conditions during en-
graftment and cartilage formation. Therefore, the preservation
FIG. 2. Chondrocyte metabolic phenotype is sensitive to glucose level. Oxidative phosphorylation (A) and glycolytic ac-
tivity (B) are shown for freshly isolated cells (day 0) and cells expanded in monolayer for four population doublings. Com-
bined, these data indicate metabolic sensitivity to glucose concentration at both day 0 and after expansion, such that cells in
1mM glucose derived a greater proportion of ATP from aerobic metabolism (C). Reactive oxygen species, determined by the
rate of increase in dihydroethidium fluorescence, increased with monolayer expansion (D), but was significantly lower fol-
lowing expansion for four population doublings in 1mM glucose compared to 10mM glucose. Data represents the mean and
SD from four donors (n = 4), and p-values represent two-tailed t-tests with Bonferroni correction for multiple comparisons.
ROS, reactive oxygen species; DHE, dihydroethidium.
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of the differentiation and capacity to form cartilage achieved
by expansion in low-glucose conditions must be retained in
different conditions to maintain clinical relevance. To test
the reversibility of the phenotype and of the cartilage formation
capacity, chondrocytes were first expanded in either high or low
glucose, but then cultured as pellets in low glucose. Also in this
case, chondrocytes expanded in high glucose were associated
with poorer cartilage formation in pellet culture under these
conditions (Fig. 5A–C). Thus, high-glucose conditions during
the expansion phase irreversibly reduced the potential for carti-
lage formation in pellet culture. However, once in pellet culture,
high-glucose conditions favored cartilage formation (greater
wet weight, total GAG and collagen, ANOVA p<0.01), in
keeping with previous reports.37 To summarize the data so
far, during the expansion phase, low-glucose conditions better
and irreversibly preserved the expression of chondrocyte differ-
entiation markers and increased subsequent cartilage formation
in 3D pellet culture; however, once in pellet culture, high-
glucose conditions favored the formation of ECM.
Discussion
Culture expansion is a necessary step in ACI, but it is as-
sociated with a loss of the differentiated chondrocyte pheno-
type known as dedifferentiation,6,7 a reduced capacity to
form stable cartilage in vivo4,12,13,38 and ultimately with a
poorer clinical outcome of ACI.10,11 In this study we have
demonstrated that expanded chondrocytes are metabolically
sensitive to glucose concentration, undergoing a transient
suppression of oxidative phosphorylation and increased
ROS production in high glucose. This was followed by a re-
duced expression of chondrocyte differentiation markers at
the end of the expansion phase compared with low-glucose
conditions and an irreversible loss of cartilage formation ca-
pacity in 3D pellet culture.
Chondrocytes expanded in low glucose media took 2 days
longer to reach 4 PDs (Fig. 1D). Despite this additional time
in vitro required to reach four PDs, the low-glucose samples
exhibited superior chondrogenic potential in comparison to
high-glucose conditions. Therefore, the additional culture
time seems an acceptable cost considering that enhanced
cell quality would reduce treatment failure rates and thus re-
quirement for re-interventions.4,10,11 Indeed, in a trial in
which retention of chondrocyte differentiation markers was
used as a quality control, 11.8% of the patients (6 patients
out of 57) could not receive the treatment because the chon-
drocytes had insufficient retention of phenotypic traits.9,39
These patients had already received surgery in order to ob-
tain a cartilage biopsy and start chondrocyte expansion,
such that an additional 2 days required to achieve the same
FIG. 3. The effect of glucose level on chondrocyte metabolic phenotype is largely reversible. Oxidative phosphorylation
(A) and glycolytic activity (B), proportion of ATP from aerobic metabolism (C) and reactive oxygen species (ROS) gener-
ation (D) are shown for cells expanded in monolayer for four population doublings in either 1mM or 10mM glucose. The
data compare cell metabolism in the respective expansion media and in cells exposed to short-term (< 1 h) switchover of glu-
cose levels to assess reversibility of metabolic traits developed during expansion. Data represents the mean and SD from four
donors (n = 4), and p-values represent two-tailed t-tests.
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level of cell expansion while preserving chondrocyte quality
seemed worthwhile in terms of patient benefit and resources.
It is interesting to note that although the chondrocytes in
high-glucose conditions initially proliferated faster, they
subsequently stopped dividing at around 30 PDs, whereas
chondrocytes in low-glucose conditions still displayed a
nearly linear growth curve at 80 PDs (Supplementary Fig.
S1). Although this is not relevant to chondrocyte expansion
for tissue engineering applications since chondrocytes are
expanded for much shorter time, such a reduced population
doubling limit is often a feature of cumulative cell
stress,33,34,40 which may have biological consequences dur-
ing the long remodeling that the repair tissue undergoes
in vivo prior to maturation.41 For example, oxidative stress
may reduce the anabolic response of human articular
chondrocytes to insulin-like growth factor-142 or induce a
hypertrophic phenotype.43,44 Furthermore, the difference in
longevity in vitro may be taken into account for the expan-
sion of mesenchymal stem cells for which low-glucose con-
ditions may warrant higher expansion capacity.
FIG. 4. mRNA expression
of phenotypic and catabolic
markers after four population
doublings. The mRNA ex-
pression of three phenotypic
markers SOX9, COL2A1,
and Aggrecan following four
population doublings in
1mM glucose is compared to
expansion in 10mM glucose
(A). The expression of
MMP13, COL10A1, and
PTGS2, involved in catabo-
lism and hypertrophy, is il-
lustrated in (B). mRNA
values were normalized to the
geometric mean of b-actin
and B2M reference genes and
freshly isolated (day 0)
chondrocytes. Data represent
the mean –SEM of at least
four donors, and statistical
comparisons were made
using t-tests, paired to limit
the effect of donor-to-donor
variability.
FIG. 5. The glucose level during the culture expansion phase irreversibly affects subsequent tissue formation in pellet cul-
ture. Chondrocytes expanded in 1mM glucose produced micropellets with greater wet weight (A) and containing more GAG
(B) and collagen (C) compared with chondrocytes expanded in 10mM glucose. Data represents the mean – SEM of pellets
from eight chondrocyte donors (n = 8), and p-values represent two-tailed paired t-tests.
GLUCOSE LEVELS & CHONDROCYTE FUNCTION 15
In this study, monolayer expansion in 1mM glucose had fa-
vorable effects on phenotypic expression profiles (increased
SOX9, COL2A1) and reduced expression of catabolic
MMP13 compared to typical 10mM glucose media. An asso-
ciation between levels of these differentiation markers in
monolayer and subsequent cartilage formation in 3D has
been examined previously.4,11,45 However, existing literature
regarding the optimal glucose environment for retention
of such phenotypic expression profiles in vitro is scarce and
predominantly focuses on the effects of short-term exposure
to exceptionally high glucose levels, such as found in hyper-
glycemia. For example, Rosa et al.46 examined the effect of
media containing 30mM glucose on human chondrocyte phe-
notype in comparison to 10mM glucose. By contrast, this
study examines physiological glucose levels compared to typ-
ical culture media used in ACI. To put the values used in our
study in context, the glucose concentration in synovial fluid is
1.4mM lower than arterial plasma, which is regulated between
4 and 6mM in healthy humans15,47,48 and is estimated to reach
levels as low as*1mM deep within the cartilage.15,16
Expansion in low glucose represents an effective, safe, and
inexpensive option to increase the quality of repair in ACI.
Our findings may be further exploited in alternative tissue
engineering practices where the cells are seeded into a scaf-
fold and cultured for a further period in vitro (where glucose
can be controlled and monitored). Here, our findings indicate
an optimal protocol would be a combination of low-glucose
conditions during expansion followed by high glucose during
the 3D phase.
Two caveats are important in terms of relevance to chon-
drocyte transplantation. In this study we used bovine chon-
drocytes, which may experience lower glucose levels
in vivo49 and altered uptake kinetics16,50 compared with
human chondrocytes such that glucose concentrations cannot
be directly extrapolated to human chondrocytes. The 3D pel-
let culture system we used in this study is not directly vali-
dated to predict efficacy in ACI in humans. Therefore, our
results warrant further substantiation in appropriate validated
in vivo models such as the cartilage formation assay in nude
mice described by Dell’Accio et al.4,9,39
In our study, the preservation of the cartilage phenotype
and increased cartilage formation associated with expansion
in low-glucose conditions was also associated with relatively
increased oxidative phosphorylation and lower ROS produc-
tion measured during the expansion phase (Fig. 2). However,
while the effects of glucose concentration on oxygen metab-
olism and ROS generation were mostly transient (they were
not retained following media switch-over, Fig. 3), the loss of
cartilage-forming capacity on transfer to pellet culture was
persistent (Fig. 4). Thus glucose conditions, specifically in
the expansion phase, may induce modifications that condition
subsequent cartilage formation in pellet culture. This is consis-
tent with epigenetic modification during proliferation.51–53
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3D¼ three-dimensional
ACI¼ autologous chondrocyte implantation
ANOVA¼ analysis of variance
B2M¼ b2 microglobulin
bNAD¼ b nicotinamide adenine dinucleotide
COL10A1¼ collagen, type X, alpha 1
COL2A1¼ collagen, type II, alpha 1
DMEM¼Dulbecco’s modified Eagle’s medium
ECM¼ extracellular matrix
FCS¼ fetal calf serum
MMP13¼matrix metallopeptidase 13
PD¼ population doubling
PTGS2¼ prostaglandin-endoperoxide synthase 2
qPCR¼ quantitative polymerase chain reaction
ROS¼ reactive oxygen species
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